Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06018350 · ClinicalTrials.gov registry record · NA
Medication Adherence in Rheumatic Diseases
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT06018350 is a NA study that has completed, run by Duke University. The registered enrollment target is 102 participants.
The verdict
NCT06018350, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The investigators will pilot test a clinician-led intervention to improve medication adherence in general rheumatology clinic across a spectrum of rheumatic diseases. The study will assess feasibility, acceptability, and fidelity, and explore signal for improved medication adherence.
Interventions
- BEHAVIORAL Clinician-led adherence intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2024-02-02 |
| Est. Completion | 2024-06-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06018350
The ClinicalTrials.gov registry entry for NCT06018350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinician-led adherence intervention is the first listed.
NCT06018350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06018350 about?
NCT06018350 is a clinical study titled "Medication Adherence in Rheumatic Diseases". The investigators will pilot test a clinician-led intervention to improve medication adherence in general rheumatology clinic across a spectrum of rheumatic diseases. The study will assess feasibility, acceptability, and fidelity, and explore signal for improved medication adherence.
What is the current status of trial NCT06018350?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2024-02-02. Estimated completion is 2024-06-22.
What interventions are being tested in trial NCT06018350?
The interventions under investigation include: Clinician-led adherence intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06018350?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.